GOLDEN, Colo., Jan. 6, 2016 /PRNewswire/ -- Following the successful completion of The Angel® Catheter Clinical Trial, BiO2Medical, Inc. reports that it has raised approximately $9 ...
Key Angel® Catheter Article Publication and Ongoing Pivotal Investigation Progress of the Angel® Catheter Clinical Trial
GOLDEN, Colo., Oct. 8, 2015 /PRNewswire/ -- BiO2 Medical is pleased to announce the publication of key clinical data on the use of the Angel® Catheter in Europe. ...
GOLDEN, Colo., Dec. 18, 2015 /PRNewswire/ -- BiO2 Medical is pleased to announce that The Angel® Catheter Clinical Trial, the pivotal investigation of the Angel® Catheter, has successfully ...
BiO2 Medical Executes Q4 2013 Commercialization Strategy for the Angel® Catheter, Signing Distribution Partnership Agreements in Key European and Middle Eastern Geographies
BiO2 Medical has achieved Q4 2013 global expansion goals for the Angel® Catheter, a novel Central Venous Catheter (CVC) with a permanently attached retrievable Inferior Vena Cava (IVC) filter to provide Pulmonary Embolism (PE) protection for critically ill patients. The Angel® Catheter is the first ...